← Leaderboards
Francesca Schiaffino
Universidad Peruana Cayetano Heredia
$659,105
Attributed
$659,105
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $202.3K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$659,105 · 1
By mechanism
K43$659,105 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Antibiotics”
- Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
- Urs Oschner · Crestone, Inc.$8,499,692
- Brian Kane · Spero Therapeutics, Inc.$6,712,318
- M.r.k. (dickon) Alley · An2 Therapeutics, Inc.$4,957,446
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Robert Pease Smith · Tufts University Boston$3,652,652
Research focus
AntibioticsAnimalsAntimicrobial ResistanceAttentionAntimicrobialBirdsCampylobacterCampylobacter ColiCampylobacter InfectionCampylobacter JejuniCareer DevelopmentChickensChildChildhoodClinically RelevantCommensal MicrobesCommunicable DiseasesCommunitiesCommunity Based Participatory ResearchCountryDesignDevelopment PlansDiarrheaDisease Model
Grant awards (5)
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country$152,280
K43 · FY2025 · TW · contact PI
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country$49,985
K43 · FY2025 · TW · contact PI
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country$152,280
K43 · FY2024 · TW · contact PI
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country$152,280
K43 · FY2023 · TW · contact PI
Genomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income Country$152,280
K43 · FY2022 · TW · contact PI